A Smarter Approach to Mastitis Treatment for Modern Dairy Farms

Introduction

Antimicrobial stewardship refers to the actions taken by veterinarians and producers to protect the effectiveness and availability of antibiotics for the future. Today, it is no longer just a buzzword. It is a critical part of modern dairy herd management. 

On dairy farms, most antibiotics are used to treat clinical mastitis and to prevent new infections at dry off time. However, antibiotic use varies widely between farms. This variation shows that mastitis management is a key opportunity to optimize antibiotic use. 

Over the past decades, dairy farms have made major improvements in hygiene, milking routines, housing, and cow comfort. These changes have led to better udder health. This progress reinforces a key principle: prevention remains the foundation of any successful udder health program.  

As herd management has improved, the types of bacteria causing mastitis have also changed. In the past, many cases of clinical mastitis were caused by contagious pathogens such as Streptococcus agalactiae. Today, many cases are caused by environmental gram-negative bacteria, such as Escherichia coli. 

Another important shift is seen in milk culture results. When milk samples from clinical mastitis cases are cultured, about 25-35% show no bacterial growth. In many of these cases, the cow’s immune system has already cleared the infection. Treating these cows with antibiotics offers no clinical benefit and no economic return. 

The foundation of modern antimicrobial stewardship is selective treatment. The goals of treatment are to achieve both a clinical and bacteriological cure while minimizing negative health and economic impacts. Mastitis treatment protocols should always be developed with the herd veterinarian and follow a selective approach tailored to each individual case. 

Clinical Mastitis

For clinical mastitis, this approach uses diagnostic information to guide treatment decisions instead of treating every case the same way. Aseptic milk sample collection is critical to identify the bacteria causing mastitis and guide treatment decisions. Diagnostic tests, whether done on the farm or through a laboratory, can identify the likely pathogen causing mastitis within 24 hours. Although diagnostics require time and labor, these costs are often offset by savings from reduced drug use and less discarded milk.  

Selective dry cow therapy

Selective dry cow therapy follows the same principle, treating only cows with evidence of infection rather than treating every cow and every quarter (blanket treatment). Farms that adopt this approach commonly reduce overall antibiotic use by 40-50%, while maintaining udder health and milk quality. 

A smarter approach to mastitis treatment

A smarter approach to mastitis treatment considers several key factors. 

• Pathogen type. A proper diagnosis helps determine if antibiotics are needed. Treatment should be reserved for cases with a higher chance of bacteriological cure. Research shows that treating Gram-positive infections leads to higher cure rates. Gram-negative and culture-negative cases should not be treated because they often resolve on their own. 
• Cow history. Before starting treatment, review the cow’s characteristics including parity, stage of lactation, and udder health history, both clinical and subclinical. Younger cows and cows without a history of subclinical mastitis have greater odds of achieving bacteriological clearance and fewer recurrences. Chronic cases and cows with repeated high somatic cell counts are less likely to respond to treatment and may require alternative management strategies. 
• Severity of the case. Severe cases with fever or signs of systemic illness require immediate intervention, including supportive care such as fluids and anti-inflammatory drugs. In non-severe cases with symptoms like abnormal milk or swollen udder only, research consistently shows that waiting up to 24 hours for culture results before starting antibiotics (if they are really needed) does not reduce cure rates or compromise cow welfare. 

As pressure to reduce antibiotic use grows, many non-FDA-approved alternative products have entered the market. These products are often promoted using testimonials rather than science. Most lack evidence from independent clinical trials and producers should evaluate them with caution. 

Author

 

Carolina Pinzón-Sánchez

Bilingual Dairy Outreach Specialist – As a statewide Dairy Outreach Specialist, Carolina identifies needs and incorporates research findings into high-quality outreach education programs around dairy production.

Articles by Carolina Pinzón-Sánchez

Contact Carolina Pinzón-Sánchez